Literature DB >> 25123827

Surface tailoring of nanoparticles via mixed-charge monolayers and their biomedical applications.

Xiangsheng Liu1, Huan Li, Qiao Jin, Jian Ji.   

Abstract

The recent convergence of nanomaterials and medicine has provided an expanding horizon for people to achieve encouraging advances in many biomedical applications such as cancer diagnosis and therapy. However, to realize desirable functions in the rather complex biological systems, a suitable surface coating is greatly in need for nanoparticles (NPs), regardless of the species. In this review, a recently developed surface modification strategy is highlighted--mixed-charge monolayers--with an emphasis on the nanointerfaces of inorganic NPs. Two typical mixed-charge gold NPs (AuNPs) prepared from surface modifications with different combinations of oppositely charged alkanethiols are shown as detailed examples to discuss how the mixed-charge monolayer can help NPs meet the criteria for in vitro and in vivo biomedical applications, including those critical issues like colloidal stability, nonfouling properties, and smart responses (pH-sensitivity) for tumor targeting.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  mixed-charge monolayers; nanoparticles; surface modification; tumor targeting; zwitterionic

Mesh:

Substances:

Year:  2014        PMID: 25123827     DOI: 10.1002/smll.201401440

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  7 in total

Review 1.  Diverse Applications of Nanomedicine.

Authors:  Beatriz Pelaz; Christoph Alexiou; Ramon A Alvarez-Puebla; Frauke Alves; Anne M Andrews; Sumaira Ashraf; Lajos P Balogh; Laura Ballerini; Alessandra Bestetti; Cornelia Brendel; Susanna Bosi; Monica Carril; Warren C W Chan; Chunying Chen; Xiaodong Chen; Xiaoyuan Chen; Zhen Cheng; Daxiang Cui; Jianzhong Du; Christian Dullin; Alberto Escudero; Neus Feliu; Mingyuan Gao; Michael George; Yury Gogotsi; Arnold Grünweller; Zhongwei Gu; Naomi J Halas; Norbert Hampp; Roland K Hartmann; Mark C Hersam; Patrick Hunziker; Ji Jian; Xingyu Jiang; Philipp Jungebluth; Pranav Kadhiresan; Kazunori Kataoka; Ali Khademhosseini; Jindřich Kopeček; Nicholas A Kotov; Harald F Krug; Dong Soo Lee; Claus-Michael Lehr; Kam W Leong; Xing-Jie Liang; Mei Ling Lim; Luis M Liz-Marzán; Xiaowei Ma; Paolo Macchiarini; Huan Meng; Helmuth Möhwald; Paul Mulvaney; Andre E Nel; Shuming Nie; Peter Nordlander; Teruo Okano; Jose Oliveira; Tai Hyun Park; Reginald M Penner; Maurizio Prato; Victor Puntes; Vincent M Rotello; Amila Samarakoon; Raymond E Schaak; Youqing Shen; Sebastian Sjöqvist; Andre G Skirtach; Mahmoud G Soliman; Molly M Stevens; Hsing-Wen Sung; Ben Zhong Tang; Rainer Tietze; Buddhisha N Udugama; J Scott VanEpps; Tanja Weil; Paul S Weiss; Itamar Willner; Yuzhou Wu; Lily Yang; Zhao Yue; Qian Zhang; Qiang Zhang; Xian-En Zhang; Yuliang Zhao; Xin Zhou; Wolfgang J Parak
Journal:  ACS Nano       Date:  2017-03-14       Impact factor: 15.881

2.  Targeted drug delivery using iRGD peptide for solid cancer treatment.

Authors:  Xiangsheng Liu; Jinhong Jiang; Ying Ji; Jianqin Lu; Ryan Chan; Huan Meng
Journal:  Mol Syst Des Eng       Date:  2017-08-16

3.  Fluorescent Carbon Dots from Nerium oleander: Effects of Physical Conditions and the Extract Types.

Authors:  Sinem Simsek; Melis Ozge Alas; Belma Ozbek; Rukan Genc
Journal:  J Fluoresc       Date:  2019-06-18       Impact factor: 2.217

4.  Self-Complementary Zwitterionic Peptides Direct Nanoparticle Assembly and Enable Enzymatic Selection of Endocytic Pathways.

Authors:  Richard H Huang; Nazia Nayeem; Ye He; Jorge Morales; Duncan Graham; Rafal Klajn; Maria Contel; Stephen O'Brien; Rein V Ulijn
Journal:  Adv Mater       Date:  2021-10-20       Impact factor: 32.086

5.  The influence of nanocarrier architectures on antitumor efficacy of docetaxel nanoparticles.

Authors:  Zhengqi Dong; Xiangtao Wang; Shuang Zhao; Hanhong Qiu; Meihua Han; Jingguo Li; Ning Zhao; Rui Wang; Yifei Guo
Journal:  RSC Adv       Date:  2020-03-17       Impact factor: 4.036

Review 6.  Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.

Authors:  Wei Wu; Li Luo; Yi Wang; Qi Wu; Han-Bin Dai; Jian-Shu Li; Colm Durkan; Nan Wang; Gui-Xue Wang
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

7.  Introduction of lactobionic acid ligand into mixed-charge nanoparticles to realize in situ triggered active targeting to hepatoma cells.

Authors:  H Li; X Li; Y Wang; J Ji
Journal:  Mater Today Bio       Date:  2019-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.